M&A Deal Summary

Candela Acquires Ultrashape

On February 8, 2012, Candela acquired medical products company Ultrashape for 12M USD

Acquisition Highlights
  • This is Candela’s 6th transaction in the Medical Products sector.
  • This is Candela’s largest (disclosed) transaction.
  • This is Candela’s 3rd transaction in Israel.

M&A Deal Summary
Date 2012-02-08
Target Ultrashape
Sector Medical Products
Buyer(s) Candela
Deal Type Add-on Acquisition
Deal Value 12M USD

Target

Ultrashape

Yoqneam, Israel
Ultrashape Ltd. is a developer, manufacturer and marketer of innovative non-invasive technologies for fat cell destruction and body sculpting. Ultrashape's products are approved and commercially available in Europe, Canada, Latin America and Asia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Candela

Marlborough, Massachusetts, United States
Category Company
Founded 1970
Sector Medical Products
Revenue 278M USD (2015)
DESCRIPTION

Candela is a US-based global medical aesthetic device company. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical-aesthetic applications including benign vascular and pigmented lesions, scars, hair removal, facial resurfacing, wrinkle reduction, women's health treatments, tattoo removal, acne, leg veins, cellulite, and body shaping. Candela was formed in 1970 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 7 of 10
Sector (Medical Products) 6 of 8
Type (Add-on Acquisition) 6 of 9
Country (Israel) 3 of 5
Year (2012) 1 of 3
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-08 Pharos Life

Cambridge, Ontario, Canada

Pharos Life Corp. is a manufacturer of home-use light therapy for aesthetic procedures. Company products are marketed directly to consumers through premium retailers under the Tända™ brand name and include products for skincare and wellness solutions for both the home-use and professional markets.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-12 TransPharma Medical

Lod, Israel

TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. TransPharma has developed an innovative transdermal drug delivery technology based on RF-MicroChannels that create microscopic channels across the skin. Its first product, the Viador system, is a handheld device with an RF-needle array. It is CE Mark approved for use in transdermal delivery of biologic drug-products via a system-specific skin patch.

Buy -
Mergr

Product

Company

Legal